Results 101 to 110 of about 3,193 (174)

Hughes-Stovin Syndrome. [PDF]

Open Respir Arch
Romero Sayago C, Vázquez Vázquez M, Díaz Chantar F.   +2 more
europepmc   +1 more source

Diferentes doses de ciclofosfamida no sistema imune de ovinos

, 2017
The purpose of the present work was to evaluate different dosis effect of cyclophosphamide (CY) as an immunosuppressor in ovine. Thirty animals were grouped into four categories: groups I, II and III received 10, 25 e 40mg kg-1 of CY and group IV ...
Porto, Ana Carolina Rusca, Feres, Flavia Corbari, Garcia, Mauricio, Martins, Maria de Fatima, Diegues, Andre Dias, Figueira, Yara Ferreira, Chate, Sabrina Caruso   +6 more
core  

Current treatment of lupus nephritis: an overview of the new guidelines. [PDF]

J Bras Nefrol
Sales GTM, Macedo NJ, Reis Neto ETD, Kirsztajn GM.   +3 more
europepmc   +1 more source

A hospital management algorithm for acute poisoning by Paraquat® in a pediatric population, a series of cases [PDF]

Biomedica
Padilla-Guzmán A, Prado OL, Ballesteros D, Rivera V, Bravo Y, Murillo L, Narváez S, Forero JM.   +7 more
europepmc   +1 more source

Cognitive impairments associated with chemotherapy in women with breast cancer: a meta-analysis and meta-regression. [PDF]

Braz J Med Biol Res, 2023
Oliveira MEC, Torres GSV, Franklin RG, Gomes KAL, Nóbrega WFS, Fernandes TP, Santos NA.   +6 more
europepmc   +1 more source

Steroid-Refractory Cutaneous Graft-versus-Host Disease: a Case Report [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Appeceix S, Vicente G, Comacchio F, Fernandez Otero L.   +3 more
europepmc   +1 more source

[Narcolepsy secondary to a rare fatal disease]. [PDF]

Rev Neurol, 2023
Fontana-García N, Ivanovic-Barbeito YP, Martín-Palomeque G, Buenache-Espartosa R, Valera-Dávila CE, Pedrera-Mazarro A.   +5 more
europepmc   +1 more source

Eosinophilic myocarditis in Churg-Strauss disease: Case report [PDF]

Arch Cardiol Mex, 2022
Barmak M, Scatularo CE, Giraldo A, Pellegrini A.   +3 more
europepmc   +1 more source

[Clinical spectrum, neuroimaging and therapeutic response to neurological syndromes associated with anti-GAD65]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Salomón LF, Sánchez-Galván DMS, Galván-Heredia P, Mejía-Chávez JA, Solís-Luna SM, Aguayo Jiménez CE.   +5 more
europepmc   +1 more source

Ciclofosfamida en glomerulonefritis primarias y secundarias

Nefrología, 2010
openaire   +1 more source